BridgeBio Pharma, Inc. (BBIO)
77.93
+3.64
(+4.90%)
USD |
NASDAQ |
Nov 09, 16:00
77.86
-0.07
(-0.09%)
Pre-Market: 09:21
BridgeBio Pharma Cash and Short Term Investments (Quarterly) : 1.539B for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.539B |
| June 30, 2026 | 720.71M |
| March 31, 2026 | 940.74M |
| December 31, 2025 | 588.03M |
| September 30, 2025 | 646.07M |
| June 30, 2025 | 757.34M |
| March 31, 2025 | 540.72M |
| December 31, 2024 | 681.23M |
| September 30, 2024 | 405.73M |
| June 30, 2024 | 587.18M |
| March 31, 2024 | 519.82M |
| December 31, 2023 | 451.54M |
| September 30, 2023 | 559.92M |
| June 30, 2023 | 403.72M |
| March 31, 2023 | 516.80M |
| December 31, 2022 | 509.85M |
| Date | Value |
|---|---|
| September 30, 2022 | 592.12M |
| June 30, 2022 | 715.84M |
| March 31, 2022 | 671.40M |
| December 31, 2021 | 836.84M |
| September 30, 2021 | 599.79M |
| June 30, 2021 | 837.84M |
| March 31, 2021 | 919.26M |
| December 31, 2020 | 607.09M |
| September 30, 2020 | 710.68M |
| June 30, 2020 | 840.94M |
| March 31, 2020 | 905.18M |
| December 31, 2019 | 545.99M |
| September 30, 2019 | 536.05M |
| June 30, 2019 | 293.80M |
| March 31, 2019 | 373.03M |
| December 31, 2018 | 436.09M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 3.587B |
| Ionis Pharmaceuticals, Inc. | 1.884B |
| Pfizer Inc. | 14.27B |
| Cytokinetics, Inc. | 1.133B |
| Vertex Pharmaceuticals, Inc. | 6.313B |